Sector ratings Bio-Rad Laboratories, Inc.

Stocks

Real-time Estimate Cboe BZX Other stock markets 02:47:33 06/08/26 am AEST			5-day change	1st Jan Change
342.42 ^USD	+2.87%		+5.00%	+13.41%

10:47pm	RBC Adjusts Price Target on Bio-Rad Laboratories to $370 From $320, Maintains Outperform Rating	MT
05/08	Bio-Rad Laboratories, Inc., Q2 2026 Earnings Call, Aug 04, 2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	ESG MSCI	Global Valuation
BIO-RAD LABORATORIES, INC.	8.93B	BBB
ABBOTT LABORATORIES	182B	BBB
MEDTRONIC PLC	110B	BBB
CENCORA, INC.	59.59B	AA
HOYA CORPORATION	55.04B	AAA
BECTON, DICKINSON AND COMPANY	46.87B	A
MEDLINE INC.	35.55B	A
DEXCOM, INC.	32.81B	BBB
WEST PHARMACEUTICAL SERVICES, INC.	24.54B	AA
STERIS PLC	22.69B	AAA	-
TERUMO CORPORATION	21.75B	AA
SARTORIUS STEDIM BIOTECH	19.37B	BBB
ZIMMER BIOMET HOLDINGS, INC.	18.54B	A
SOLVENTUM CORPORATION	15.23B	BBB
BAXTER INTERNATIONAL INC.	14.66B	A
FISHER & PAYKEL HEALTHCARE CORPORATION LIMITED	14.6B	A
ALIGN TECHNOLOGY, INC.	12.41B	A
INSULET CORPORATION	11.55B	A
GLOBUS MEDICAL, INC.	11.06B	CCC
AVANTOR, INC.	9.25B	AA
Average	36.36B	A
Weighted average by Cap.		A